Medicine
Dextrose 25 g/50 mL injection
Dextrose 25 g/50 mL injection is a generic prescription medicine for intravenous use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Dextrose
- Brand
- Sold under the generic name
- Strength
- 25 g/50 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 25 vials of 50 mL, 10 cartons of 50 mL, 1 syringe of 50 mL and 12 more
- Manufacturers
- HealthFirstMedical Purchasing SolutionsHenry ScheinHospiraProPharma DistributionInternational Medication SystemsRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B05CX01 Dextrose
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 March 2005
- Identifiers
- RxCUI 727517, 1795514DailyMed set ID 763b1cb8-1151-5f59-e053-2991aa0a4e01, 8cf6943f-16e8-4521-863c-09bb0b55e2a9, 40fd1ac4-39bb-45fb-ba99-4fb65481f231 +10NDC 51662-1216, 0404-9845, 0404-9847 +11Application NDA019445, ANDA203451
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, single-dose in 1 tray / 50 mL in 1 vial, single-dose | 0409-6648-02 | Hospira | 31 March 2005 |
| 10 carton in 1 container / 1 syringe, plastic in 1 carton / 50 mL in 1 syringe, plastic | 0409-7517-16 | Hospira | 2 December 2005 |
| 1 syringe in 1 carton / 50 mL in 1 syringe | 76329-3302-1 | International Medication Systems | 11 November 2021 |
| 50 mL in 1 vial, single-dose | 51662-1215-1 | HealthFirst | 13 September 2018 |
| 1 syringe, plastic in 1 carton / 50 mL in 1 syringe, plastic | 51662-1216-1 | HealthFirst | 19 September 2018 |
| 1 syringe in 1 carton / 50 mL in 1 syringe | 51662-1584-1 | HealthFirst | 11 February 2022 |
| 10 pouch in 1 case / 1 syringe in 1 pouch / 50 mL in 1 syringe | 51662-1584-3 | HealthFirst | 11 February 2022 |
| 1 carton in 1 bag / 1 syringe, plastic in 1 carton / 50 mL in 1 syringe, plastic | 71872-7003-1 | Medical Purchasing Solutions | 28 February 2018 |
| 1 vial, single-dose in 1 bag / 50 mL in 1 vial, single-dose | 71872-7057-1 | Medical Purchasing Solutions | 5 March 2018 |
| 1 syringe in 1 bag / 50 mL in 1 syringe | 71872-7282-1 | Medical Purchasing Solutions | 1 March 2022 |
| 1 syringe in 1 bag / 50 mL in 1 syringe | 0404-9845-50 | Henry Schein | 10 January 2022 |
| 1 vial, single-dose in 1 bag / 50 mL in 1 vial, single-dose | 0404-9847-50 | Henry Schein | 10 January 2022 |
| 50 mL in 1 syringe, plastic | 84549-517-16 | ProPharma Distribution | 27 August 2025 |
| 50 mL in 1 vial, single-dose | 84549-648-02 | ProPharma Distribution | 13 October 2026 |
| 10 carton in 1 container / 1 syringe, plastic in 1 carton / 50 mL in 1 syringe, plastic | 70518-4219-0 | Remedyrepack | 23 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 January 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dextrose
Clinical summary
Dextrose is a prescription medicine indicated as source of water and calories in adult and pediatric patients, and may also be used as a diluent for reconstitution of a powder or liquid drug product. MedsAcross supplies Dextrose for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DextroseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DEXTROSE prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Dextrose 25 g/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.